{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T01:56:44Z","timestamp":1792634204705,"version":"4.5.0"},"reference-count":91,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,1,20]],"date-time":"2021-01-20T00:00:00Z","timestamp":1611100800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:p>Intranasal (IN) administration appears to be a suitable route for clinical use as it allows direct delivery of bioactive molecules to the central nervous system, reducing systemic exposure and sides effects. Nevertheless, only some molecules can be transported to the brain from the nasal cavity. This led us to compare the efficiency of an IN, intravenous (IV), and intraperitoneal (IP) administration of pituitary adenylate cyclase-activating polypeptide (PACAP) after transient or permanent middle cerebral artery occlusion (MCAO) in C57BL\/6 mice. The results show that the neuroprotective effect of PACAP is much more efficient after IN administration than IV injection while IP injection had no effect. IN administration of PACAP reduced the infarct volume when injected within 6\u00a0h after the reperfusion and improved functional recovery up to at least 1 week after the ischemia.<\/jats:p>","DOI":"10.3389\/fendo.2020.585082","type":"journal-article","created":{"date-parts":[[2021,1,20]],"date-time":"2021-01-20T07:02:15Z","timestamp":1611126135000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":29,"title":["Intranasal Administration of PACAP Is an Efficient Delivery Route to Reduce Infarct Volume and Promote Functional Recovery After Transient and Permanent Middle Cerebral Artery Occlusion"],"prefix":"10.3389","volume":"11","author":[{"given":"Asma","family":"Cherait","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Maucotel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Lefranc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e9r\u00f4me","family":"Leprince","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Vaudry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,1,20]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(99)04407-4","article-title":"Treatment and secondary prevention of stroke: evidence, costs, and effects on individuals and populations","volume":"354","author":"Hankey","year":"1999","journal-title":"Lancet"},{"key":"B2","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1159\/000210432","article-title":"Classification of stroke subtypes","volume":"27","author":"Amarenco","year":"2009","journal-title":"Cerebrovasc Dis (Basel Switzerland)"},{"key":"B3","doi-asserted-by":"publisher","first-page":"634","DOI":"10.2471\/BLT.16.181636","article-title":"Stroke: a global response is needed","volume":"94","author":"Johnson","year":"2016","journal-title":"Bull World Health Organ"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/4650104","article-title":"Stroke event factors among adult patients admitted to stroke unit of Jimma university medical center: Prospective Observational Study","volume":"4650104","author":"Fekadu","year":"2019","journal-title":"Stroke Res Treat"},{"key":"B5","volume-title":"The global burden of cerebrovascular disease in the year 2000. GBD 2000 working paper","author":"Truelsen","year":"2000"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1038\/s41582-018-0002-2","article-title":"Protecting the ischaemic penumbra as an adjunct to thrombectomy for acute stroke","volume":"14","author":"Baron","year":"2018","journal-title":"Nat Rev Neurol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1096\/fj.201601209r","article-title":"Combination therapy with liposomal neuroprotectants and tissue plasminogen activator for treatment of ischemic stroke","volume":"31","author":"Fukuta","year":"2017","journal-title":"FASEB J"},{"key":"B8","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1136\/svn-2015-000004","article-title":"Endovascular thrombectomy for stroke: current best practice and future goals","volume":"1","author":"Campbell","year":"2016","journal-title":"Stroke Vasc Neurol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.109.552547","article-title":"Efficacy and safety of tissue plasminogen activator 3 to 4.5 hours after acute ischemic stroke: a metaanalysis","volume":"40","author":"Lansberg","year":"2009","journal-title":"Stroke"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S56071","article-title":"Animal models of ischemic stroke and their application in clinical research","volume":"9","author":"Fluri","year":"2015","journal-title":"Drug Des Dev Ther"},{"key":"B11","first-page":"269","article-title":"Pituitary adenylate cyclase-activating polypeptide and its receptors: from structure to functions","volume":"52","author":"Vaudry","year":"2000","journal-title":"Pharmacol Rev"},{"key":"B12","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1111\/j.1476-5381.2012.01871.x","article-title":"Pharmacology and functions of receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide: IUPHAR review 1","volume":"166","author":"Harmar","year":"2012","journal-title":"Br J Pharmacol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1124\/pr.109.001370","article-title":"Pituitary adenylate cyclase-activating polypeptide and its receptors: 20 years after the discovery","volume":"61","author":"Vaudry","year":"2009","journal-title":"Pharmacol Rev"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroscience.2009.02.028","article-title":"Distribution and functional characterization of pituitary adenylate cyclase\u2013activating polypeptide receptors in the brain of non-human primates","volume":"160","author":"Jolivel","year":"2009","journal-title":"Neuroscience"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.npep.2013.10.005","article-title":"PACAP and PAC1 receptor in brain development and behavior","volume":"47","author":"Shen","year":"2013","journal-title":"Neuropeptides"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.2174\/1381612824666181112110934","article-title":"Alternative routes of administration of the neuroprotective pituitary adenylate cyclase activating polypeptide","volume":"24","author":"Reglodi","year":"2018","journal-title":"Curr Pharm Des"},{"key":"B17","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1159\/000064942","article-title":"Multiple actions of pituitary adenylyl cyclase activating peptide in nervous system development and regeneration","volume":"24","author":"Waschek","year":"2002","journal-title":"Dev Neurosci"},{"key":"B18","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1007\/s12031-008-9087-1","article-title":"Inhibitory effect of PACAP on caspase activity in neuronal apoptosis: a better understanding towards therapeutic applications in neurodegenerative diseases","volume":"36","author":"Dejda","year":"2008","journal-title":"J\u00a0Mol Neurosci"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.5483\/BMBRep.2014.47.7.086","article-title":"Neuroprotective roles of pituitary adenylate cyclase-activating polypeptide in neurodegenerative diseases","volume":"47","author":"Lee","year":"2014","journal-title":"BMB Rep"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2174\/0929867327666200320162436","article-title":"Implications of VIP and PACAP in parkinson\u2019s disease: What do we know so far","volume":"27","author":"De Souza","year":"2020","journal-title":"Curr Med Chem"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3791\/237610.1016\/j.bbadis.2016.01.005","article-title":"Effect of the pituitary adenylate cyclase-activating polypeptide on the autophagic activation observed in in vitro and in vivo models of Parkinson\u2019s disease","volume":"1862","author":"Lamine-Ajili","year":"2016","journal-title":"Biochim Biophys Acta"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1242\/dmm.027185","article-title":"Pituitary adenylate cyclase-activating polypeptide (PACAP) has a neuroprotective function in dopamine-based neurodegeneration in rat and snail parkinsonian models","volume":"10","author":"Maasz","year":"2017","journal-title":"Dis Models Mech"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1096\/fj.10-180133","article-title":"Neuropeptide pituitary adenylate cyclase-activating polypeptide (PACAP) slows down Alzheimer\u2019s disease-like pathology in amyloid precursor protein-transgenic mice","volume":"25","author":"Rat","year":"2011","journal-title":"FASEB J"},{"key":"B24","doi-asserted-by":"publisher","first-page":"283","DOI":"10.3390\/molecules23020283","article-title":"Peptides as potential therapeutics for alzheimer\u2019s disease","volume":"23","author":"Ribari","year":"2018","journal-title":"Molecules"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-170531","article-title":"A decade of blood biomarkers for alzheimer\u2019s disease research: an evolving field, improving study designs, and the challenge of replication","volume":"62","author":"Shi","year":"2018","journal-title":"J Alzheimers Dis"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.peptides.2015.08.006","article-title":"PACAP as a neuroprotective factor in ischemic neuronal injuries","volume":"72","author":"Shioda","year":"2015","journal-title":"Peptides"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-018-0972-5","article-title":"Pituitary adenylate cyclase-activating polypeptide (PACAP) enhances hippocampal synaptic plasticity and improves memory performance in huntington\u2019s disease","volume":"55","author":"Cabezas-Llobet","year":"2018","journal-title":"Mol Neurobiol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.peptides.2011.04.003","article-title":"PACAP and a novel stable analog protect rat brain from ischemia: Insight into the mechanisms of action","volume":"32","author":"Dejda","year":"2011","journal-title":"Peptides"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.2174\/138161211795049679","article-title":"Protective effects of pituitary adenylate cyclase-activating polypeptide (PACAP) against apoptosis","volume":"17","author":"Seaborn","year":"2011","journal-title":"Curr Pharm Des"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.mcn.2014.08.007","article-title":"PACAP induces plasticity at autonomic synapses by nAChR-dependent NOS1 activation and AKAP-mediated PKA targeting","volume":"63","author":"Jayakar","year":"2014","journal-title":"Mol Cell Neurosci"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.114.006864","article-title":"Delayed pituitary adenylate cyclase-activating polypeptide delivery after brain stroke improves functional recovery by inducing m2 microglia\/macrophage polarization","volume":"46","author":"Brifault","year":"2015","journal-title":"Stroke"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1007\/s12031-016-0731-x","article-title":"Pituitary adenylate cyclase-activating polypeptide (PACAP) is involved in adult mouse hippocampal neurogenesis after stroke","volume":"59","author":"Matsumoto","year":"2016","journal-title":"J Mol Neurosci"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.3390\/ijms19041020","article-title":"Review on PACAP-induced transcriptomic and proteomic changes in neuronal development and repair","volume":"19","author":"Rivnyak","year":"2018","journal-title":"Int J Mol Sci"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.peptides.2008.01.022","article-title":"Novel stable PACAP analogs with potent activity towards the PAC1 receptor","volume":"29","author":"Bourgault","year":"2008","journal-title":"Peptides"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3995\/jstroke.8.1","article-title":"Experimental studies of ischemic brain edema 1. A new experimental model of cerebral embolism in rats in which recirculation can be introduced in the ischemic area","volume":"8","author":"Koizumi","year":"1986","journal-title":"Jpn J Stroke"},{"key":"B36","doi-asserted-by":"publisher","first-page":"2376","DOI":"10.3791\/2376","article-title":"Assessment of motor balance and coordination in mice using the balance beam","volume":"49","author":"Luong","year":"2011","journal-title":"J Vis Exp"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1038\/nprot.2009.125","article-title":"The adhesive removal test: a sensitive method to assess sensorimotor deficits in mice","volume":"4","author":"Bouet","year":"2009","journal-title":"Nat Protoc"},{"key":"B38","doi-asserted-by":"publisher","first-page":"84","DOI":"10.3791\/237610.1161\/01.str.20.1.84","article-title":"Reversible middle cerebral artery occlusion without craniectomy in rats","volume":"20","author":"Longa","year":"1989","journal-title":"Stroke"},{"key":"B39","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.regpep.2006.06.016","article-title":"Neuroprotection by endogenous and exogenous PACAP following stroke","volume":"137","author":"Chen","year":"2006","journal-title":"Regul Pept"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1111\/j.1747-4949.2012.00839.x","article-title":"Pathophysiologic cascades in ischemic stroke","volume":"7","author":"Xing","year":"2012","journal-title":"Int J Stroke"},{"key":"B41","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1186\/s12974-019-1516-2","article-title":"Neuroinflammation: friend and foe for ischemic stroke","volume":"16","author":"Jayaraj","year":"2019","journal-title":"J Neuroinflammation"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.1641-15.2015","article-title":"In vivo inhibition of miR-155 promotes recovery after experimental mouse stroke","volume":"35","author":"Caballero-Garrido","year":"2015","journal-title":"J Neurosci"},{"key":"B43","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.regpep.2004.02.016","article-title":"Anorexigenic effects of pituitary adenylate cyclase-activating polypeptide and vasoactive intestinal peptide in the chick brain are mediated by corticotrophin-releasing factor","volume":"120","author":"Tachibana","year":"2004","journal-title":"Regul Pept"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1016\/j.peptides.2005.02.022","article-title":"Inhibitory effects of pituitary adenylate cyclase-activating polypeptide (PACAP) and vasoactive intestinal peptide (VIP) on food intake in the goldfish, Carassius auratus","volume":"26","author":"Matsuda","year":"2005","journal-title":"Peptides"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2019.00227","article-title":"Expression patterns of PACAP and PAC1R genes and anorexigenic action of PACAP1 and PACAP2 in zebrafish","volume":"10","author":"Nakamachi","year":"2019","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1038\/npp.2015.34","article-title":"Pituitary adenylate cyclase-activating peptide in the central amygdala causes anorexia and body weight loss via the melanocortin and the trkb systems","volume":"40","author":"Iemolo","year":"2015","journal-title":"Neuropsychopharmacology"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2016.00383","article-title":"Pituitary adenylate-cyclase activating polypeptide regulates hunger- and palatability-induced binge eating","volume":"10","author":"Hurley","year":"2016","journal-title":"Front Neurosci"},{"key":"B48","article-title":"Comparative neuroprotective effects of preischemic PACAP and VIP administration in permanent occlusion of the middle cerebral artery in rats","volume":"23","author":"Tam\u00e1s","year":"2002","journal-title":"Neuro Endocrinol Lett"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1016\/j.peptides.2005.11.010","article-title":"Pituitary adenylate cyclase-activating peptide (PACAP): assessment of dipeptidyl peptidase IV degradation, insulin-releasing activity and antidiabetic potential","volume":"27","author":"Green","year":"2006","journal-title":"Peptides"},{"key":"B50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2015\/160928","article-title":"Emerging role of pacap as a new potential therapeutic target in major diabetes complications","volume":"160928","author":"Marzagalli","year":"2015","journal-title":"Int J Endocrinol"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1002\/stem.1915","article-title":"PACAP38\/PAC1 signaling induces bone marrow-derived cells homing to ischemic brain","volume":"33","author":"Lin","year":"2015","journal-title":"Stem Cells (Dayton Ohio)"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1016\/j.peptides.2012.05.021","article-title":"Intranasal administration of PACAP: uptake by brain and regional brain targeting with cyclodextrins","volume":"36","author":"Nonaka","year":"2012","journal-title":"Peptides"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.1526-09.2009","article-title":"PACAP neurons in the hypothalamic ventromedial nucleus are targets of central leptin signaling","volume":"29","author":"Hawke","year":"2009","journal-title":"J Neurosci"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1038\/npp.2014.8","article-title":"PACAP in the BNST produces anorexia and weight loss in male and female rats","volume":"39","author":"Kocho-Schellenberg","year":"2014","journal-title":"Neuropsychopharmacology"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1152\/ajpgi.00190.2015","article-title":"PACAP intraperitoneal treatment suppresses appetite and food intake via PAC1 receptor in mice by inhibiting ghrelin and increasing GLP-1 and leptin. American journal of physiology","volume":"309","author":"Vu","year":"2015","journal-title":"Gastrointest Liver Physiol"},{"key":"B56","volume-title":"Development of stable agonists of the PAC1 receptor: study of the structure-activity relationships of the pituitary adenylate cyclase activator polypeptide. Doctoral thesis in Cellular Biology. Medicinal chemistry and neuroscience","author":"Bourgault","year":"2009"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1038\/npp.2008.73","article-title":"Pituitary adenylate cyclase-activating polypeptide inhibits food intake in mice through activation of the hypothalamic melanocortin system","volume":"34","author":"Mounien","year":"2009","journal-title":"Neuropsychopharmacology"},{"key":"B58","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/j.peptides.2004.02.006","article-title":"Hypothalamic control of energy balance: different peptides, different functions","volume":"25","author":"Leibowitz","year":"2004","journal-title":"Peptides"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1097\/00001756-200408260-00004","article-title":"The amygdala is critical for opioid-mediated binge eating of fat","volume":"15","author":"Will","year":"2004","journal-title":"Neuroreport"},{"key":"B60","unstructured":"Intranasal drug administration \u2014 an attractive delivery route for some drugs\n            MarxD\n            WilliamsG\n            BirkhoffM\n          Drug discovery and development- from molecules to medicine2015"},{"key":"B61","first-page":"27","volume-title":"Therapeutic potential of intranasal drug delivery in preclinical studies of ischemic stroke and intracerebral hemorrhage","author":"Li","year":"2019"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1208\/s12248-015-9719-7","article-title":"Intranasal delivery of proteins and peptides in the treatment of neurodegenerative diseases","volume":"17","author":"Meredith","year":"2015","journal-title":"AAPS J"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(11)70066-7","article-title":"Stroke and the immune system: from pathophysiology to new therapeutic strategies","volume":"10","author":"Macrez","year":"2011","journal-title":"Lancet Neurol"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1038\/jcbfm.2011.186","article-title":"The two pathophysiologies of focal brain ischemia: implications for translational stroke research","volume":"32","author":"Hossmann","year":"2012","journal-title":"J Cereb Blood Flow Metab"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1007\/s12031-012-9818-1","article-title":"Multimodal neuroprotection induced by PACAP38 in oxygen-glucose deprivation and middle cerebral artery occlusion stroke models","volume":"48","author":"Lazarovici","year":"2012","journal-title":"J Mol Neurosci"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1007\/s12031-014-0309-4","article-title":"PACAP38 suppresses cortical damage in mice with traumatic brain injury by enhancing antioxidant activity","volume":"54","author":"Miyamoto","year":"2014","journal-title":"J Mol Neurosci"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0600375103","article-title":"Pituitary adenylate cyclase-activating polypeptide (PACAP) decreases ischemic neuronal cell death in association with IL-6","volume":"103","author":"Ohtaki","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1007\/s12031-012-9762-0","article-title":"PACAP is an endogenous protective factor-insights from PACAP-deficient mice","volume":"48","author":"Reglodi","year":"2012","journal-title":"J Mol Neurosci"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1007\/s12640-011-9254-y","article-title":"Mice deficient in pituitary adenylate cyclase activating polypeptide (PACAP) are more susceptible to retinal ischemic injury in vivo","volume":"21","author":"Szabadfi","year":"2012","journal-title":"Neurotox Res"},{"key":"B70","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/s0005-2736(00)00295-9","article-title":"Desensitization, surface expression, and glycosylation of a functional, epitope-tagged type I PACAP (PAC(1)) receptor","volume":"1509","author":"Shintani","year":"2000","journal-title":"Biochim Biophys Acta"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1038\/nn.3569","article-title":"Regulation of interneuron excitability by gap junction coupling with principal cells","volume":"16","author":"Apostolides","year":"2013","journal-title":"Nat Neurosci"},{"key":"B72","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1186\/s12864-018-5039-5","article-title":"Genome-wide transcriptome analysis using RNA-Seq reveals a large number of differentially expressed genes in a transient MCAO rat model","volume":"19","author":"Dergunova","year":"2018","journal-title":"BMC Genomics"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainresbull.2017.02.011","article-title":"The role of aquaporin-4 in synaptic plasticity, memory and disease","volume":"136","author":"Hubbard","year":"2018","journal-title":"Brain Res Bull"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/6316059","article-title":"Cerebral Ischemic Postconditioning Plays a Neuroprotective Role through Regulation of Central and Peripheral Glutamate","volume":"2018","author":"You","year":"2018","journal-title":"BioMed Res Int"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1038\/72256","article-title":"Aquaporin-4 deletion in mice reduces brain edema after acute water intoxication and ischemic stroke","volume":"6","author":"Manley","year":"2000","journal-title":"Nat Med"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1177\/0271678X15623290","article-title":"Improved long-term outcome after transient cerebral ischemia in aquaporin-4 knockout mice","volume":"37","author":"Hirt","year":"2017","journal-title":"J Cereb Blood Flow Metab"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.0000124127.57946.a1","article-title":"Volume-regulated anion channels are the predominant contributors to release of excitatory amino acids in the ischemic cortical penumbra","volume":"35","author":"Feustel","year":"2004","journal-title":"Stroke"},{"key":"B78","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/83358","article-title":"The proteolytic activity of tissue-plasminogen activator enhances NMDA receptor-mediated signaling","volume":"7","author":"Nicole","year":"2001","journal-title":"Nat Med"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1177\/1545968314543652","article-title":"GABA levels are decreased after stroke and GABA changes during rehabilitation correlate with motor improvement","volume":"29","author":"Blicher","year":"2015","journal-title":"Neurorehabil Neural Repair"},{"key":"B80","doi-asserted-by":"publisher","first-page":"194","DOI":"10.4103\/2045-9912.215750","article-title":"The role of nitric oxide in stroke","volume":"7","author":"Chen","year":"2017","journal-title":"Med Gas Res"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/9324018","article-title":"Crosstalk between Calcium and ROS in Pathophysiological Conditions","volume":"2019","author":"Feno","year":"2019","journal-title":"Oxid Med Cell Longevity"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1038\/nature05515","article-title":"Gadd45a promotes epigenetic gene activation by repair-mediated DNA demethylation","volume":"445","author":"Barreto","year":"2007","journal-title":"Nature"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1111\/jnc.13020","article-title":"Comparison of the deleterious effects of binge drinking-like alcohol exposure in adolescent and adult mice","volume":"132","author":"Lacaille","year":"2015","journal-title":"J Neurochem"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1177\/0271678X16674488","article-title":"Unfolded protein response in brain ischemia: A timely update","volume":"36","author":"Yang","year":"2016","journal-title":"J Cereb Blood Flow Metab"},{"key":"B85","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.nbd.2008.06.014","article-title":"PACAP prevents toxicity induced by cisplatin in rat and primate neurons but not in proliferating ovary cells: involvement of the mitochondrial apoptotic pathway","volume":"32","author":"Aubert","year":"2008","journal-title":"Neurobiol Dis"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2008.01.005","article-title":"Mechanisms of ischemic brain damage","volume":"55","author":"Doyle","year":"2008","journal-title":"Neuropharmacology"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.0820-04.2004","article-title":"Absence of glial fibrillary acidic protein and vimentin prevents hypertrophy of astrocytic processes and improves post-traumatic regeneration","volume":"24","author":"Wilhelmsson","year":"2004","journal-title":"J Neurosci"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1002\/stem.1196","article-title":"Astrocytes negatively regulate neurogenesis through the Jagged1-mediated Notch pathway","volume":"30","author":"Wilhelmsson","year":"2012","journal-title":"Stem Cells (Dayton Ohio)"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.118.022888","article-title":"Extracellular vimentin\/VWF (von willebrand factor) interaction contributes to vwf string formation and stroke pathology","volume":"49","author":"Fasipe","year":"2018","journal-title":"Stroke"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2010.07.002","article-title":"The science of stroke: mechanisms in search of treatments","volume":"67","author":"Moskowitz","year":"2010","journal-title":"Neuron"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinbiochem.2008.08.080","article-title":"Pro-inflammatory and anti-inflammatory cytokines in acute ischemic stroke and their relation to early neurological deficit and stroke outcome","volume":"41","author":"Basic Kes","year":"2008","journal-title":"Clin Biochem"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2020.585082\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,20]],"date-time":"2021-01-20T07:02:20Z","timestamp":1611126140000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2020.585082\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,20]]},"references-count":91,"alternative-id":["10.3389\/fendo.2020.585082"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2020.585082","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,20]]},"article-number":"585082"}}